These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34040322)

  • 1. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.
    Hartl L; Elias J; Prager G; Reiberger T; Unger LW
    World J Gastroenterol; 2021 May; 27(19):2281-2298. PubMed ID: 34040322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for bariatric surgery in patients with cirrhosis.
    Goh GB; Schauer PR; McCullough AJ
    World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
    Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
    Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
    JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
    Verrastro O; Panunzi S; Castagneto-Gissey L; De Gaetano A; Lembo E; Capristo E; Guidone C; Angelini G; Pennestrì F; Sessa L; Vecchio FM; Riccardi L; Zocco MA; Boskoski I; Casella-Mariolo JR; Marini P; Pompili M; Casella G; Fiori E; Rubino F; Bornstein SR; Raffaelli M; Mingrone G
    Lancet; 2023 May; 401(10390):1786-1797. PubMed ID: 37088093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.
    Tsochatzis E; Coilly A; Nadalin S; Levistky J; Tokat Y; Ghobrial M; Klinck J; Berenguer M
    Transplantation; 2019 Jan; 103(1):45-56. PubMed ID: 30153225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
    Shelley K; Articolo A; Luthra R; Charlton M
    BMC Gastroenterol; 2023 May; 23(1):160. PubMed ID: 37208593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis.
    Navarro-Masip È; Mestres N; Zorzano-Martínez M; Salinas-Roca B; Sánchez E; López-Cano C; Herrerías F; de la Fuente MC; Santamaría M; León-Mengíbar J; Soler AG; Bueno M; Lecube A
    Obes Surg; 2024 Mar; 34(3):841-849. PubMed ID: 38285299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ?
    Binet Q; Loumaye A; Preumont V; Thissen JP; Hermans MP; Lanthier N
    Acta Gastroenterol Belg; 2022; 85(2):346-357. PubMed ID: 35709779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese.
    Strey CBM; de Carli LA; Fantinelli M; Gobbato SS; Bassols GF; Losekann A; Coral GP
    Ann Hepatol; 2018 July - August ,; 17(4):585-591. PubMed ID: 29893699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.
    Bai J; Jia Z; Chen Y; Li Y; Zheng S; Duan Z
    World J Surg; 2022 May; 46(5):1122-1133. PubMed ID: 35275232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Steatohepatitis: A Review.
    Sheka AC; Adeyi O; Thompson J; Hameed B; Crawford PA; Ikramuddin S
    JAMA; 2020 Mar; 323(12):1175-1183. PubMed ID: 32207804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric Surgery in Cirrhotic Patients: Is It Safe?
    Younus H; Sharma A; Miquel R; Quaglia A; Kanchustambam SR; Carswell KA; Patel AG
    Obes Surg; 2020 Apr; 30(4):1241-1248. PubMed ID: 31853866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.